Ethan R. Goldman

Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 865,963 shares of common stock for an aggregate price to the public of approximately $143.75 million,…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of an additional $300 million aggregate principal amount of 6.250%…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by DENTSPLY SIRONA Inc. of $750 million aggregate principal amount of…

Davis Polk advised the underwriters in connection with SEC-registered offerings by Discovery Communications, LLC of $1 billion aggregate principal amount of 3.625% senior notes due 2030 and…

Davis Polk advised the joint book-running managers in connection with a $325 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…

Davis Polk advised Clarios International LP, formerly the Power Solutions business of Johnson Controls International plc, in connection with a Rule 144A/Regulation S offering of $500…

Davis Polk the initial purchasers in connection with a Rule 144A offering by Cantel Medical Corp. of $140 million principal amount of 3.250% convertible senior notes due 2025. Cantel’s…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering by First American Financial Corporation of …

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a SEC-registered follow-on offering of 4,573,863 shares of common stock…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Ingredion Incorporated of $600 million aggregate principal amount of 2.900%…